Get the Stockscreener App
11.66
4.95%
0.55
After Hours:
11.66
Daxor Corporation stock is traded at $11.66, with a volume of 6,000.
It is up +4.95% in the last 24 hours and up +2.46% over the past month.
Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
See More
Previous Close:
$11.11
Open:
$11.61
24h Volume:
6,000
Relative Volume:
0.22
Market Cap:
$56.40M
Revenue:
$2.61M
Net Income/Loss:
$1.69M
P/E Ratio:
38.83
EPS:
0.3003
Net Cash Flow:
-
1W Performance:
+5.42%
1M Performance:
+2.46%
6M Performance:
+42.89%
1Y Performance:
+24.44%
1-Day Range:
$11.40
$11.66
1-Week Range:
$11.00
$11.70
52-Week Range:
$6.55
$11.70
Daxor Corporation Stock (DXR) Company Profile
Name
Daxor Corporation
Sector
Industry
Phone
212-330-8500
Address
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Compare DXR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
11.66 | 56.66M | 2.61M | 1.69M | 0 | 0.3003 |
|
ISRG
Intuitive Surgical Inc
|
449.68 | 161.31B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
186.84 | 54.01B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
270.14 | 39.60B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
78.29 | 38.49B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
253.50 | 18.35B | 2.96B | 487.70M | 344.00M | 6.68 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-16-19 | Initiated | Ascendiant Capital Markets | Buy |
Daxor Corporation Stock (DXR) Latest News
Is Daxor Corporation stock ready for a breakout2025 Risk Factors & Technical Buy Zone Confirmations - Newser
Is Daxor Corporation trending in predictive chart modelsSell Signal & Free Safe Entry Trade Signal Reports - Newser
How institutional ownership impacts Daxor Corporation stockWeekly Gains Report & Growth Focused Entry Point Reports - Newser
Risk adjusted return profile for Daxor Corporation analyzedShare Buyback & Fast Gain Stock Tips - Newser
Understanding Daxor Corporation’s price movementGlobal Markets & Smart Money Movement Tracker - Newser
Daxor Corporation stock trend outlook and recovery pathJuly 2025 Opening Moves & Safe Entry Point Alerts - Newser
Analyzing recovery setups for Daxor Corporation investorsWeekly Loss Report & Accurate Technical Buy Alerts - Newser
Daxor Corporation stock daily chart insights2025 Market Overview & Fast Moving Stock Watchlists - Newser
Analyzing drawdowns of Daxor Corporation with statistical toolsQuarterly Earnings Summary & Weekly Sector Rotation Insights - Newser
Volume spikes in Daxor Corporation stock – what they meanIPO Watch & Entry Point Strategy Guides - Newser
Applying big data sentiment scoring on Daxor CorporationJuly 2025 Retail & Free Safe Entry Trade Signal Reports - Newser
What does recent volatility data suggest for Daxor CorporationJuly 2025 Gainers & Comprehensive Market Scan Reports - Newser
Custom watchlist performance reports with Daxor CorporationQuarterly Growth Report & Verified Short-Term Trading Plans - Newser
Building trade automation scripts for Daxor CorporationWeekly Loss Report & Accurate Intraday Trading Signals - Newser
Daxor Corporation stock retracement – recovery analysisRate Cut & Low Risk Growth Stock Ideas - Newser
Heatmap analysis for Daxor Corporation and competitorsPortfolio Risk Report & Weekly Watchlist of Top Performers - Newser
Ranking Daxor Corporation among high performing stocks via toolsStock Surge & Safe Capital Allocation Plans - Newser
Can Daxor Corporation hit a new high this monthEarnings Summary Report & Daily Oversold Stock Bounce Ideas - Newser
Detecting price anomalies in Daxor Corporation with AIWeekly Loss Report & Low Drawdown Investment Ideas - Newser
Predicting Daxor Corporation trend using moving averages2025 Performance Recap & Verified Trade Idea Suggestions - Newser
Analyzing Daxor Corporation with risk reward ratio chartsWeekly Earnings Recap & Verified Momentum Stock Alerts - Newser
Can Daxor Corporation rally from current levelsTrend Reversal & Safe Capital Allocation Plans - Newser
What candlestick patterns are forming on Daxor CorporationJuly 2025 Highlights & Daily Stock Trend Watchlist - Newser
can daxor corporation hit a new high this month2025 Analyst Calls & Momentum Based Trading Signals - Newser
What indicators show strength in Daxor CorporationJuly 2025 EndofMonth & Low Drawdown Momentum Ideas - Newser
Using data models to predict Daxor Corporation stock movementJuly 2025 Sentiment & Safe Entry Point Alerts - Newser
Daxor Corporation Stock (DXR) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):